From stones to system: integrating kidney stones disease into the cardiovascular-kidney-metabolic continuum.
PMID: 41491965 · 2026
JournalCurrent opinion in nephrology and hypertension
Year2026
PMID41491965
Abstract
To reposition kidney stone disease within the cardiovascular-kidney-metabolic continuum and synthesize recent evidence on therapeutics, clinician-supervised digital monitoring, and value-based care implementation to modernize prevention and follow-up. Epidemiology shows a rise in kidney stone disease prevalence across cardiovascular-kidney-metabolic stages independent of demographics. Comparative-effectiveness analyses suggest fewer stone events with sodium-glucose cotransporter-2 inhibitor(s) v
Official Source
View on PubMed →Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.